Showing 1 - 4 results of 4 for search 'Maria Callejo', query time: 0.06s Refine Results
  1. 1
    Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat mode... by Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Bianca Barreira, Bianca Barreira, Bianca Barreira, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Maria Callejo, Maria Callejo, Maria Callejo, Rachele Pandolfi, Rachele Pandolfi, Rachele Pandolfi, Palmira Villa-Valverde, Palmira Villa-Valverde, Ignacio Rodríguez, Ignacio Rodríguez, Angel Cogolludo, Angel Cogolludo, Angel Cogolludo, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Laura Moreno, Laura Moreno, Laura Moreno

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model by Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Daniel Morales-Cano, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Jose Luis Izquierdo-García, Bianca Barreira, Bianca Barreira, Bianca Barreira, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Sergio Esquivel-Ruiz, Maria Callejo, Maria Callejo, Maria Callejo, Rachele Pandolfi, Rachele Pandolfi, Rachele Pandolfi, Palmira Villa-Valverde, Palmira Villa-Valverde, Ignacio Rodríguez, Ignacio Rodríguez, Angel Cogolludo, Angel Cogolludo, Angel Cogolludo, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Jesus Ruiz-Cabello, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Laura Moreno, Laura Moreno, Laura Moreno

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension

    Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension by Isabel Blanco, Isabel Blanco, Isabel Blanco, Maribel Marquina, Olga Tura-Ceide, Olga Tura-Ceide, Olga Tura-Ceide, Olga Tura-Ceide, Elisabet Ferrer, Elisabet Ferrer, Elisabet Ferrer, Ana M. Ramírez, Manuel Lopez-Meseguer, Maria Callejo, Maria Callejo, Francisco Perez-Vizcaino, Francisco Perez-Vizcaino, Victor Ivo Peinado, Victor Ivo Peinado, Victor Ivo Peinado, Victor Ivo Peinado, Joan Albert Barberà, Joan Albert Barberà, Joan Albert Barberà

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension

    Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension by Daniel Morales-Cano, Bianca Barreira, Beatriz De Olaiz Navarro, María Callejo, Gema Mondejar-Parreño, Sergio Esquivel-Ruiz, Jose A. Lorente, Laura Moreno, Joan A. Barberá, Ángel Cogolludo, Francisco Perez-Vizcaino

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: